Literature DB >> 23349446

High-risk patients following hospitalisation for an acute exacerbation of COPD.

Jacques Piquet1, Jean-Michel Chavaillon, Philippe David, Francis Martin, François Blanchon, Nicolas Roche.   

Abstract

The aim of this study was to assess long-term mortality and predictive factors of death after hospital admission for acute exacerbation of chronic obstructive pulmonary disease (COPD). 1824 patients (23.2% female; mean age 70.3±11.3 years) consecutively admitted for acute exacerbation of COPD in the respiratory medicine departments of 68 general hospitals between October 2006 and June 2007 were prospectively enrolled in a follow-up cohort. Their vital status was documented between October 2010 and April 2011. Vital status was available for 1750 patients (95.9%), among whom 787 (45%) died during follow-up. Multivariate analysis found that age (60-80 years and ≥80 years versus <60 years, relative risk 2.99, 95% CI 2.31-3.89), lower body mass index (25-30 kg·m(-2) versus ≤20 kg·m(-2), relative risk 0.80, 95% CI 0.66-0.97), lung cancer (relative risk 2.08, 95% CI 1.43-3.01), cardiovascular comorbidity (relative risk 1.35, 95% CI 1.16-1.58), previous hospital admissions for acute exacerbation of COPD (four or more versus none, relative risk 1.91, 95% CI 1.44-2.53), use of accessory respiratory muscles (relative risk 1.19, 95% CI 1.01-1.40) or lower-limb oedema (relative risk 1.74, 95% CI (1.44-2.12)) at admission and treatment by long-term oxygen therapy at discharge (relative risk 2.09, 95% CI 1.79-2.45) were independent risk factors of death. Mortality rate during the 4 years following hospital admission for acute exacerbation of COPD was high (45%). Simple clinical information relating to respiratory and general status can help in identifying high-risk patients and targeting more intensive follow-up and care. Interestingly, cardiovascular comorbidities and past hospitalisations for acute exacerbation of COPD, but not forced expiratory volume in 1 s, independently predicted the risk of death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23349446     DOI: 10.1183/09031936.00180312

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  36 in total

1.  Predicting 1-year mortality rate for patients admitted with an acute exacerbation of chronic obstructive pulmonary disease to an intensive care unit: an opportunity for palliative care.

Authors:  Cassandra M Batzlaff; Craig Karpman; Bekele Afessa; Roberto P Benzo
Journal:  Mayo Clin Proc       Date:  2014-03-19       Impact factor: 7.616

2.  One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease.

Authors:  María-Teresa García-Sanz; Juan-Carlos Cánive-Gómez; Laura Senín-Rial; Jorge Aboal-Viñas; Alejandra Barreiro-García; Eva López-Val; Francisco-Javier González-Barcala
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 3.  Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Authors:  Joaquim Gea; Carme Casadevall; Sergi Pascual; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: a cohort study.

Authors:  Cristóbal Esteban; Inmaculada Arostegui; Susana Garcia-Gutierrez; Nerea Gonzalez; Iratxe Lafuente; Marisa Bare; Nerea Fernandez de Larrea; Francisco Rivas; José M Quintana
Journal:  Respir Res       Date:  2015-12-22

5.  Recruiting Patients After Hospital Discharge for Acute Exacerbation of COPD: Challenges and Lessons Learned.

Authors:  Gary T Ferguson; Bonnie Beck; Emmanuelle Clerisme-Beaty; Dacheng Liu; Byron M Thomashow; Robert A Wise; Richard ZuWallack; Barry J Make
Journal:  Chronic Obstr Pulm Dis       Date:  2017-08-10

Review 6.  Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators.

Authors:  Swati Gulati; J Michael Wells
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

7.  Comparison of clinical efficacy between ultra-LABAs and ultra-LAMAs in COPD: a systemic review with meta-analysis of randomized controlled trials.

Authors:  Eun Yeong Cho; Se Yong Kim; Min-Ji Kim; Seonwoo Kim; Dong Ah Park; Kwang Ha Yoo; Yong Bum Park; Yong Il Hwang; Chin Kook Rhee; Ji Ye Jung; Hyun Lee; Hye Yun Park
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

8.  Predictors of one-year mortality after hospitalization for an exacerbation of COPD.

Authors:  Cristóbal Esteban; Ady Castro-Acosta; Carlos Jose Alvarez-Martínez; Alberto Capelastegui; José Luis López-Campos; Francisco Pozo-Rodriguez
Journal:  BMC Pulm Med       Date:  2018-01-25       Impact factor: 3.317

Review 9.  Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?

Authors:  G P Currie; B J Lipworth
Journal:  QJM       Date:  2015-11-11

10.  Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study.

Authors:  Youngmee Kim; Ye-Jee Kim; Yu Mi Kang; Won-Kyung Cho
Journal:  BMC Pulm Med       Date:  2021-05-06       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.